Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6LVL

Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative

Summary for 6LVL
Entry DOI10.2210/pdb6lvl/pdb
Related6LVK
DescriptorFibroblast growth factor receptor 2, SULFATE ION, N-ethyl-2-[[4-[[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]-1,3,5-triazin-2-yl]amino]benzenesulfonamide (3 entities in total)
Functional Keywordsprotein kinase, signaling protein, transferase
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight73160.19
Authors
Echizen, Y.,Tateishi, Y.,Amano, Y. (deposition date: 2020-02-04, release date: 2020-04-08, Last modification date: 2023-11-29)
Primary citationKuriwaki, I.,Kameda, M.,Hisamichi, H.,Kikuchi, S.,Iikubo, K.,Kawamoto, Y.,Moritomo, H.,Kondoh, Y.,Amano, Y.,Tateishi, Y.,Echizen, Y.,Iwai, Y.,Noda, A.,Tomiyama, H.,Suzuki, T.,Hirano, M.
Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2.
Bioorg.Med.Chem., 28:115453-115453, 2020
Cited by
PubMed: 32278710
DOI: 10.1016/j.bmc.2020.115453
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.98 Å)
Structure validation

221051

건을2024-06-12부터공개중

PDB statisticsPDBj update infoContact PDBjnumon